

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Pegloticase is a specialized intravenous medication designed to treat severe gout when other treatments haven't worked effectively. This powerful enzyme therapy helps break down uric acid crystals that cause painful gout attacks, offering hope for people who haven't found relief with traditional gout medications.
If you're dealing with chronic gout that hasn't responded to standard treatments, your doctor might consider pegloticase as an option. This medication represents a significant step forward in gout care, particularly for those facing the most challenging cases of this condition.
Pegloticase is a modified version of an enzyme called uricase that your body naturally produces in small amounts. The medication works by converting uric acid into a substance called allantoin, which your kidneys can easily eliminate from your body.
Unlike oral gout medications that you take at home, pegloticase requires administration through an IV infusion at a medical facility. This specialized delivery method ensures the medication reaches your bloodstream directly and works effectively throughout your body.
The "pegylated" part of the name refers to a special coating that helps protect the enzyme from being broken down too quickly by your immune system. This coating allows the medication to work longer and more effectively in your body.
Pegloticase treats chronic gout in adults who haven't responded well to standard treatments like allopurinol or febuxostat. Your doctor might recommend this medication if you're dealing with persistently high uric acid levels despite trying other therapies.
This medication specifically helps people with refractory chronic gout, meaning their condition hasn't improved with conventional treatments. You might be a candidate if you continue experiencing painful gout attacks or have visible tophi (uric acid crystal deposits under your skin) even while taking other medications.
Some people develop intolerance or allergic reactions to standard gout medications, making pegloticase a valuable alternative. Your healthcare provider will carefully evaluate whether this treatment matches your specific situation and medical history.
Pegloticase works by providing your body with a highly effective enzyme that breaks down uric acid much more efficiently than your natural processes. This medication is considered a strong treatment option, reserved for cases where other approaches haven't succeeded.
When you receive pegloticase through IV infusion, the enzyme immediately begins converting excess uric acid in your blood into allantoin. Your kidneys then filter out this allantoin through your urine, effectively removing the uric acid that causes gout symptoms.
The medication's strength comes from its ability to dramatically lower uric acid levels that other treatments couldn't budge. However, this power also means your doctor will monitor you closely during treatment to ensure your body responds well to the medication.
Pegloticase is administered only through intravenous infusion at a medical facility, typically every two weeks. You'll receive the medication slowly over about two hours while healthcare professionals monitor you for any reactions.
Before each infusion, your medical team will likely give you medications to help prevent allergic reactions. These might include antihistamines and corticosteroids, which help your body tolerate the treatment better.
You don't need to avoid food or drink before your infusion, but it's helpful to stay well-hydrated. Your healthcare provider will give you specific instructions about any medications to avoid before treatment, particularly other gout medications that might interfere with pegloticase's effectiveness.
Plan to spend several hours at the medical facility for each treatment session. This includes time for pre-medications, the actual infusion, and observation afterward to ensure you're feeling well before heading home.
The duration of pegloticase treatment varies significantly from person to person, depending on how well your body responds and your specific gout situation. Some people may need treatment for several months, while others might continue for a year or longer.
Your doctor will regularly check your uric acid levels to determine if the medication is working effectively. If your levels aren't dropping as expected after a few months, your healthcare provider might need to adjust your treatment plan.
Most people who respond well to pegloticase will notice improvements in their gout symptoms within the first few months of treatment. Your doctor will work with you to determine the right stopping point based on your uric acid levels and overall health improvement.
Like all powerful medications, pegloticase can cause side effects, though many people tolerate it well when properly monitored. Understanding these potential effects helps you know what to expect and when to contact your healthcare provider.
The most common side effects you might experience include nausea, bruising at the infusion site, or feeling tired after treatment. These effects are usually mild and tend to improve as your body adjusts to the medication.
More serious but less common reactions can include allergic responses during or shortly after infusion. These might involve difficulty breathing, chest tightness, or severe skin reactions. This is why you'll receive treatment in a medical facility where staff can respond quickly if needed.
Some people experience an increase in gout attacks during the first few months of treatment, which might seem counterintuitive. This happens because dissolving uric acid crystals can temporarily trigger inflammation, but this usually settles down as treatment continues.
Rare but serious side effects can include severe allergic reactions or heart-related problems. Your medical team will monitor you carefully for these possibilities and will be prepared to manage any complications that arise.
Pegloticase isn't suitable for everyone, and your doctor will carefully evaluate your medical history before recommending this treatment. People with certain genetic conditions that affect how their body processes enzymes may not be candidates for this medication.
If you have a condition called G6PD deficiency, you should not receive pegloticase as it can cause serious complications. Your doctor will likely test for this condition before starting treatment.
People with heart failure or significant heart problems may need extra caution with pegloticase, as the medication can sometimes affect heart function. Your cardiologist and rheumatologist will work together to determine if this treatment is safe for you.
Pregnant or breastfeeding women should discuss the risks and benefits carefully with their healthcare provider, as there's limited information about pegloticase's effects during pregnancy and breastfeeding.
Pegloticase is primarily available under the brand name Krystexxa in the United States. This is the most commonly prescribed form of the medication you'll encounter in medical facilities.
Your healthcare provider and insurance company will be familiar with Krystexxa when discussing treatment options and coverage. The medication is manufactured by Horizon Therapeutics and is specifically formulated for intravenous use.
Some medical facilities might refer to the medication by its generic name, pegloticase, but they're referring to the same treatment. Always confirm with your healthcare team which specific medication you're receiving.
If pegloticase isn't right for you, several other gout treatments might help manage your condition. Traditional medications like allopurinol and febuxostat remain the first-line treatments for most people with gout.
Newer options include lesinurad, which works differently by helping your kidneys eliminate uric acid more effectively. Some people find success combining different medications under their doctor's guidance.
For people who can't take standard medications, lifestyle changes become especially important. These include dietary modifications, weight management, and staying well-hydrated to help your body manage uric acid levels naturally.
Your doctor might also consider other specialized treatments or refer you to a rheumatologist who specializes in gout management. The key is finding an approach that works safely and effectively for your specific situation.
Pegloticase and allopurinol work differently and serve different purposes in gout treatment, so comparing them directly isn't straightforward. Allopurinol is typically the first medication doctors try because it's effective for most people and can be taken as a daily pill at home.
Pegloticase is generally reserved for people who haven't responded well to allopurinol or similar medications. It's more intensive, requiring medical facility visits every two weeks, but it can be dramatically effective for people with severe, treatment-resistant gout.
Most people start with allopurinol because it's easier to take and has a well-established safety profile. Pegloticase becomes an option when standard treatments haven't provided adequate relief or when someone can't tolerate other medications.
Your doctor will help you understand which medication makes the most sense for your specific situation, considering factors like your gout severity, other health conditions, and treatment history.
Q1. Is Pegloticase Safe for People with Kidney Disease?
Pegloticase can be used in people with kidney disease, and it may actually help protect your kidneys by reducing uric acid levels. However, your doctor will monitor your kidney function closely during treatment.
The medication works by converting uric acid to allantoin, which is easier for your kidneys to eliminate. This can potentially reduce the burden on your kidneys compared to having high uric acid levels.
Your healthcare provider will adjust your treatment plan based on how well your kidneys are functioning and will coordinate with your nephrologist if you have significant kidney problems.
Q2. What Should I Do if I Accidentally Miss a Pegloticase Dose?
If you miss a scheduled pegloticase infusion, contact your healthcare provider as soon as possible to reschedule. Don't try to make up for the missed dose by scheduling treatments closer together.
Your doctor will determine the best timing for your next infusion based on how long it's been since your last treatment. They may want to check your uric acid levels before proceeding with the next dose.
Missing one dose usually isn't dangerous, but it's important to maintain your treatment schedule as closely as possible for the best results.
Q3. What Should I Do if I Have an Allergic Reaction to Pegloticase?
If you experience any signs of an allergic reaction during or after pegloticase treatment, seek immediate medical attention. The medical staff administering your treatment are trained to recognize and treat allergic reactions quickly.
Signs of allergic reactions can include difficulty breathing, chest tightness, severe skin reactions, or feeling faint. These reactions are most likely to occur during the infusion or within a few hours afterward.
This is why pegloticase is always given in a medical facility where emergency treatments are readily available. Your healthcare team will be monitoring you closely throughout your treatment.
Q4. When Can I Stop Taking Pegloticase?
The decision to stop pegloticase depends on how well the medication is working and your overall response to treatment. Your doctor will regularly check your uric acid levels and assess your gout symptoms to determine the right time to consider stopping.
Some people may be able to transition to other gout medications once their uric acid levels are well-controlled. Others might need to continue pegloticase longer term to maintain their improvement.
Never stop pegloticase treatment on your own, even if you're feeling much better. Your doctor needs to monitor your transition off the medication to prevent gout flares from returning.
Q5. Can I Take Other Gout Medications While Using Pegloticase?
Your doctor will likely ask you to stop other uric acid-lowering medications like allopurinol before starting pegloticase. These medications can interfere with pegloticase's effectiveness and may increase the risk of allergic reactions.
However, you might continue taking medications for gout flare prevention, such as colchicine, especially during the first few months of treatment. Your healthcare provider will create a specific medication plan for you.
Always inform your entire healthcare team about all medications you're taking, including over-the-counter drugs and supplements, to avoid potentially harmful interactions.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.